A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

This study has been completed.
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00236795

Sponsors and Collaborators

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Investigators


Study Director:	Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trial	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.